Synoptis Pharma Sp. z o.o. is a Polish pharmaceutical manufacturer within the NEUCA group, developing and supplying products positioned across prescription medicines and consumer health categories, with portfolio availability positioned across a large share of Polish pharmacies and pharmaceutical points. Business segments include prescription medicines (with therapeutic areas including cardiology, gastroenterology, neurology, urology, ophthalmology and antibiotics), as well as dietary supplements, medical devices, hygiene products and selected diagnostic/dressing materials and other general-consumption offerings. Key brands and assets include consumer and pharmacy-facing brand lines such as Apteo, dermocosmetics under CeraPlus (including emollient and sun protection lines) and childrens vitamin product lines marketed under Kicki (eg jelly-form and lollipop-form vitamin preparations). Geographic scope is anchored in Poland with distribution reach aligned to broad pharmacy channel presence. Strategic positioning emphasizes integrated pharma and consumer health development within a pharmacy-centric ecosystem, focusing on practical health and wellbeing solutions for pharmacists, clinicians and patients supported by recognizable in-pharmacy brands.
Headquarters
Ul. Krakowiakow 65
Warsaw; Mazowieckie;
Postal Code: 02-255
Contact Details: Purchase the Synoptis Pharma Sp. z o.o. report to view the information.
Website: http://www.synoptispharma.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service